NCT00504192View on ClinicalTrials.gov

A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2009

Conditions
Advanced Biliary Tract AdenocarcinomaGemcitabineOxaliplatinCombination ChemotherapyEfficacy
Interventions
DRUG

Gemcitabine and Oxaliplatin

gemcitabine 1000mg/m2 IV on day 1 and oxaliplatin 85mg/m2 on day 2 every 2weeks

Trial Locations (1)

420-767

Soonchunhyang University Bucheon Hospital, Bucheon-si

All Listed Sponsors
lead

Soonchunhyang University Hospital

OTHER

NCT00504192 - A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer | Biotech Hunter | Biotech Hunter